Skip to main content
10x Genomics, Inc. (TXG)
NASDAQ: TXG · Real-Time Price · USD
21.37
-0.91 (-4.08%)
At close: Apr 28, 2026, 4:00 PM EDT
21.78
+0.41 (1.92%)
After-hours: Apr 28, 2026, 5:53 PM EDT

10x Genomics Revenue

In the year 2025, 10x Genomics had annual revenue of $642.82M with 5.25% growth. 10x Genomics had revenue of $166.03M in the quarter ending December 31, 2025, with 0.61% growth.

Revenue (ttm)
$642.82M
Revenue Growth
+5.25%
P/S Ratio
4.28
Revenue / Employee
$545,690
Employees
1,178
Market Cap
2.73B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2025642.82M32.04M5.25%
Dec 31, 2024610.79M-7.94M-1.28%
Dec 31, 2023618.73M102.32M19.81%
Dec 31, 2022516.41M25.92M5.28%
Dec 31, 2021490.49M191.65M64.13%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Teladoc Health 2.53B
Privia Health Group 2.12B
HealthEquity 1.31B
Omnicell 1.18B
Waystar Holding 1.10B
Doximity 637.78M
Hinge Health 587.86M
Certara 418.84M
Revenue Rankings

TXG News

More News